The Role of Active Management with Jean Hynes & Jennifer Prosek | #𝐒𝐀𝐋𝐓𝐍𝐘

TL;DR

Gene Hines, CEO of Wellington, shares her journey from starting as an administrative assistant to becoming a successful healthcare investor and CEO. She discusses Wellington's private partnership structure, the importance of alternatives in their portfolio, the exciting future of healthcare, and the need for more diversity and active management in the industry.

Transcript

hello everyone thrilled to be here um with jean hines the ceo of wellington uh gene is not just the ceo of wellington she's a great investor one of the greatest healthcare investors in the world she's also a mom of four daughters we were chatting outside and i was saying you know when you're really successful when your children become great citizen... Read More

Key Insights

• ❓ Gene Hines' journey from an administrative assistant to CEO exemplifies the opportunities available at Wellington and the importance of mentorship in career growth.
• 🤔 Wellington's private partnership structure allows for long-term thinking and counter-cyclical investments, contributing to their success.
• 🪛 The future of healthcare is promising, with innovation and demographic changes driving growth. Data-driven healthcare delivery and breakthroughs in cancer treatments are among the areas of significant potential.
• 🖐️ Active management plays a vital role in delivering alpha and managing risk in today's market environment.
• 👨‍💼 Wellington is expanding its alternatives business, with a focus on both liquid alternatives and private investments.
• ☢️ Diversity is crucial in the investment industry, and active efforts should be made to attract and retain diverse talent.
• 💗 The importance of ESG and sustainability will continue to grow, presenting both complexity and opportunities for active managers.

Questions & Answers

Q: How did Gene Hines start her career at Wellington, and what role did mentors play in her success?

Gene Hines joined Wellington as an administrative assistant and later transitioned into research. She credits a supportive mentor who encouraged her to focus on the opportunities rather than title. Hines had strong female role models on the business side but fewer on the investment side.

Q: What makes Wellington's private partnership structure special, and how does it align with their long-term investment approach?

Wellington's private partnership structure allows them to think long-term and not be driven by short-term profits. It fosters a culture of trust and fairness among partners and enables the company to be counter-cyclical in their investments. This alignment with clients' long-term goals and ability to invest for the long term has been a key factor in their success.

Q: How important are alternatives in Wellington's portfolio, and what recent expansions have they made in this area?

Wellington has been in the alternatives business since 1995, initially focusing on long-short strategies. In recent years, they have expanded into private investments, growing their alternatives business to $32 billion. Gene Hines sees alternatives as a strategic investment for Wellington and an area of future growth.

Q: What is Gene Hines' perspective on the future of healthcare, and what areas of innovation excite her the most?

Gene Hines believes this is the most exciting time to be a healthcare investor due to accelerating innovation and the demographic changes driving healthcare demand. She expects significant advancements in data-driven healthcare delivery and personalized medicine. Gene Hines specifically highlights the potential for major breakthroughs in cancer treatments driven by understanding genetic mutations.

Summary & Key Takeaways

• Gene Hines, CEO of Wellington, started her career as an administrative assistant and worked her way up in the company over the years. She credits the support of mentors and the opportunities offered by the private partnership structure for her success.

• Wellington is a 1.4 trillion dollar firm with a storied culture and a focus on long-term investing. They have a 32 billion dollar alternatives business, which includes both liquid alts and private investments.

• Gene Hines discusses the exciting future of healthcare, driven by innovation and the aging population. She highlights the potential of data and digital technology in delivering healthcare and expects major advancements in the treatment of cancers.